1. Home
  2. MIST vs FICO Comparison

MIST vs FICO Comparison

Compare MIST & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FICO
  • Stock Information
  • Founded
  • MIST 2003
  • FICO 1956
  • Country
  • MIST Canada
  • FICO United States
  • Employees
  • MIST N/A
  • FICO N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FICO Business Services
  • Sector
  • MIST Health Care
  • FICO Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • FICO Nasdaq
  • Market Cap
  • MIST 53.9M
  • FICO 48.4B
  • IPO Year
  • MIST N/A
  • FICO 1987
  • Fundamental
  • Price
  • MIST $1.11
  • FICO $2,089.48
  • Analyst Decision
  • MIST Strong Buy
  • FICO Buy
  • Analyst Count
  • MIST 2
  • FICO 12
  • Target Price
  • MIST $9.50
  • FICO $2,236.75
  • AVG Volume (30 Days)
  • MIST 1.6M
  • FICO 177.1K
  • Earning Date
  • MIST 05-20-2025
  • FICO 04-29-2025
  • Dividend Yield
  • MIST N/A
  • FICO N/A
  • EPS Growth
  • MIST N/A
  • FICO 21.78
  • EPS
  • MIST N/A
  • FICO 23.21
  • Revenue
  • MIST N/A
  • FICO $1,840,361,000.00
  • Revenue This Year
  • MIST N/A
  • FICO $17.79
  • Revenue Next Year
  • MIST N/A
  • FICO $15.57
  • P/E Ratio
  • MIST N/A
  • FICO $89.95
  • Revenue Growth
  • MIST N/A
  • FICO 14.71
  • 52 Week Low
  • MIST $0.63
  • FICO $1,240.31
  • 52 Week High
  • MIST $2.75
  • FICO $2,402.52
  • Technical
  • Relative Strength Index (RSI)
  • MIST 43.96
  • FICO 65.74
  • Support Level
  • MIST $1.28
  • FICO $2,035.94
  • Resistance Level
  • MIST $1.32
  • FICO $2,112.05
  • Average True Range (ATR)
  • MIST 0.12
  • FICO 56.11
  • MACD
  • MIST 0.02
  • FICO 14.31
  • Stochastic Oscillator
  • MIST 27.39
  • FICO 85.76

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

Share on Social Networks: